Burning Rock Secures Japanese Approval for OncoGuide OncoScreen Plus CDx, Enabling Capivasertib Therapy
Burning Rock Ltd. (NASDAQ: BNR), a China‑based medical‑technology company, announced that its OncoGuide OncoScreen Plus CDx...
Burning Rock Ltd. (NASDAQ: BNR), a China‑based medical‑technology company, announced that its OncoGuide OncoScreen Plus CDx...
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) released its Q1 2025 financial report, showing a...
Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results....
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) has entered into a strategic partnership with...
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) has released its financial results for the...
Burning Rock Ltd (NASDAQ: BNR), a China-based medical technology company, has announced another partnership in...
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) has revealed positive findings from a five-year...
Guangzhou-based medical device giant Burning Rock (NASDAQ: BNR) has announced a strategic partnership with AstraZeneca...
Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its financial results for the...
Guangzhou-based medical device giant Burning Rock Ltd (NASDAQ: BNR) has issued a notice upgrading its...
The 5th China International Import Expo (CIIE) saw US-based Eli Lilly (NYSE: LLY) announce a...
Chengdu-based medical device firm Burning Rock Biotech Ltd (NASDAQ: BNR) announced the launch of a...